SNOMED CT Editorial Advisory Group

Page tree

Versions Compared

Old Version 5

changes.mady.by.user Jim Case

Saved on

compared with

New Version 6

changes.mady.by.user Jim Case

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.



Date

2020-

05

06-

XX

02

Time:

1800 1900- 1930 2030 UTC

1100  1200- 1230 1330 PDT

Zoom Meeting Details

Topic: SNOMED Editorial Advisory Group Conference Call
Time: Jun 2, 2020 12:00 PM Pacific Time (US and Canada)

Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/97507109544?pwd=bFVCZmhYZ1I2S1JIK3U1b2VBWnBEUT09
Password: 614316

Meeting ID: 975 0710 9544

Password: 614316
International numbers available: https://snomed.zoom.us/u/daDj0O3t9

Or Skype for Business (Lync):
https://snomed.zoom.us/skype/97507109544



Attendees

Chair:

AG Members

Invitees:

 Farzaneh Ashrafi

Observers:


Apologies:

Meeting Files:


Meeting minutes:

The call recording is located here.


Objectives

  • Obtain consensus on agenda items

Discussion items

ItemDescriptionOwnerNotesAction
1Call to order and role call

Jim Case

Start recording!

 

2Conflicts of interest and agenda review

Jim Case

No conflicts noted SCALE TYPE editorial content

Daniel Karlsson

Jim Case

Based on discussion at the April 29 2020 conference call, the following is proposed to be added to the SNOMED CT Editorial guide:

  • When defining observable entities for the international release, the SCALE TYPE attribute will not be used. If extensions would like to add specific subtypes of observable entities that include the SCALE TYPE, they are free to do so.
  • When using observable entities to define clinical findings, international concepts that do not include a SCALE TYPE relationship are to be used as values for the INTERPRETS relationship. The exception to this guidance are existing "vital sign" observable entities that have been defined with the SCALE TYPE of "Quantitiative".
  •  Jim Case Gain consensus on use of observables in defining clinical findings
3Antibody vs. ImmunoglobulinFarzaneh Ashrafi

4Report from Concept inactivation workgroupPaul Amos

5Next meetingEAG

Doodle poll to be sent out for additional meeting in June

Discussion: